<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="(GW856553) BID for 4 days (provided by Glaxo-Smith-Klein under a" exact="Medical Research Council" post="Industrial Collaboration Agreement). In preliminary experiments we found that"/>
 <result pre="VZV antigen (BIKEN, The Research Foundation for Microbial Diseases of" exact="Osaka University," post="Japan) or 0.9% saline solution or an equal volume"/>
 <result pre="with 20% FCS or a whole skin digestion kit from" exact="Miltenyi Biotec" post="(Cambridge, U.K.). Single cell suspensions were obtained and subsequently"/>
 <result pre="humans in vivo. Funding This work was funded by the" exact="Medical Research Council" post="(MRC) Grand Challenge in Experimental Medicine (MICA) Grant (MR/M003833/1"/>
 <result pre="MRC New Investigator award (G0901102 to MVS), Dermatrust (to AA)," exact="British Skin Foundation" post="(BSF5012 to AA)), Institute Strategic Programme Grant funding from"/>
 <result pre="(BSF5012 to AA)), Institute Strategic Programme Grant funding from the" exact="Biotechnology and Biological Sciences Research Council" post="(BBS/E/D/20002173 to TF and NM) and National Institute for"/>
 <result pre="Biological Sciences Research Council (BBS/E/D/20002173 to TF and NM) and" exact="National Institute for Health Research" post="University College London Hospitals Biomedical Research Centre. Author contribution"/>
 <result pre="Council (BBS/E/D/20002173 to TF and NM) and National Institute for" exact="Health Research" post="University College London Hospitals Biomedical Research Centre. Author contribution"/>
 <result pre="to TF and NM) and National Institute for Health Research" exact="University College London" post="Hospitals Biomedical Research Centre. Author contribution ESC designed, performed"/>
 <result pre="at the Francis Crick Institute and Professor Mahdad Noursadeghi at" exact="University College London" post="for support in developing this project. We are also"/>
</results>
